These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16214362)
1. Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or in combination with the biguanide metformin in diabetic rats. El-Batran SA; Abdel-Salam OM; Nofal SM; Baiuomy AR Pharmacol Res; 2006 Jan; 53(1):69-74. PubMed ID: 16214362 [TBL] [Abstract][Full Text] [Related]
2. Effect of N-benzoyl-D-phenylalanine on streptozotocin-induced changes in the lipid and lipoprotein profile in rats. Ashokkumar N; Pari L; Manimekalai A; Selvaraju K J Pharm Pharmacol; 2005 Mar; 57(3):359-66. PubMed ID: 15807992 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetes. Horton ES; Foley JE; Shen SG; Baron MA Curr Med Res Opin; 2004 Jun; 20(6):883-9. PubMed ID: 15200747 [TBL] [Abstract][Full Text] [Related]
4. Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin. Hirschberg Y; Karara AH; Pietri AO; McLeod JF Diabetes Care; 2000 Mar; 23(3):349-53. PubMed ID: 10868864 [TBL] [Abstract][Full Text] [Related]
5. Effect of N-benzoyl-d-phenylalanine on lipid profile in liver of neonatal streptozotocin diabetic rats. Pari L; Ashokkumar N Fundam Clin Pharmacol; 2005 Oct; 19(5):563-8. PubMed ID: 16176335 [TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of ferulic acid with commercial hypoglycemic drugs in streptozotocin induced diabetic rats. Prabhakar PK; Prasad R; Ali S; Doble M Phytomedicine; 2013 Apr; 20(6):488-94. PubMed ID: 23490007 [TBL] [Abstract][Full Text] [Related]
7. Nateglinide improves glycaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients. Marre M; Van Gaal L; Usadel KH; Ball M; Whatmough I; Guitard C Diabetes Obes Metab; 2002 May; 4(3):177-86. PubMed ID: 12047396 [TBL] [Abstract][Full Text] [Related]
8. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats. Tunali S; Yanardag R Pharmacol Res; 2006 Mar; 53(3):271-7. PubMed ID: 16431126 [TBL] [Abstract][Full Text] [Related]
9. [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy]. Kellerer M; Jakob S; Linn T; Haslbeck M MMW Fortschr Med; 2003 Dec; 145(51-52):I-X; quiz XI-XII. PubMed ID: 14974337 [No Abstract] [Full Text] [Related]
10. Hypoglycemic effect and mechanism of a proteoglycan from ganoderma lucidum on streptozotocin-induced type 2 diabetic rats. Teng BS; Wang CD; Zhang D; Wu JS; Pan D; Pan LF; Yang HJ; Zhou P Eur Rev Med Pharmacol Sci; 2012 Feb; 16(2):166-75. PubMed ID: 22428467 [TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity. El-Bassossy HM; Abo-Warda SM; Fahmy A Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):643-9. PubMed ID: 22594672 [TBL] [Abstract][Full Text] [Related]
12. Nateglinide in combination with metformin in Chinese patients with type 2 diabetes mellitus: a post-marketing surveillance study. Yang JK; Wang L; Clin Drug Investig; 2013 Mar; 33(3):185-91. PubMed ID: 23338975 [TBL] [Abstract][Full Text] [Related]
13. Central anti-diabetic action of biguanide and thizolidinediones in D-glucose fed and streptozotocin-treated mouse models. Sim YB; Park SH; Kang YJ; Kim SS; Kim CH; Kim SJ; Jung JS; Ryu OH; Choi MG; Suh HW Neurosci Lett; 2012 Oct; 528(1):73-7. PubMed ID: 22960361 [TBL] [Abstract][Full Text] [Related]
14. Effect of an active fraction isolated from the leaf extract of Leptadenia reticulata on plasma glucose concentration and lipid profile in streptozotocin-induced diabetic rats. Venkatesan N; Anton Smith AG Chin J Nat Med; 2014 Jun; 12(6):455-60. PubMed ID: 24969527 [TBL] [Abstract][Full Text] [Related]
15. Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial. Dashora UK; Sibal L; Ashwell SG; Home PD Diabet Med; 2007 Apr; 24(4):344-9. PubMed ID: 17298589 [TBL] [Abstract][Full Text] [Related]
16. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus. Campbell IW Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991 [TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability and safety of nateglinide in combination with metformin. Results from a study under general practice conditions. Schatz H; Schoppel K; Lehwalder D; Schandry R Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):262-6. PubMed ID: 12951631 [TBL] [Abstract][Full Text] [Related]
18. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Zhang XF; Tan BK Acta Pharmacol Sin; 2000 Dec; 21(12):1157-64. PubMed ID: 11603293 [TBL] [Abstract][Full Text] [Related]
19. Gastroprotective effects of the insulin sensitizers rosiglitazone and metformin against indomethacin-induced gastric ulcers in Type 2 diabetic rats. Morsy MA; Ashour OM; Fouad AA; Abdel-Gaber SA Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):173-7. PubMed ID: 19566821 [TBL] [Abstract][Full Text] [Related]